Advertisement

Topics

Search Results for "Xarelto Vs Pradaxa"

03:16 EDT 22nd August 2017 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

STAT Plus: Pharmalot, Pharmalittle: J&J and Bayer win their first trial over alleged Xarelto harms

A federal court jury found that the companies did not mislead a Louisiana man and his doctors about the health risks of the Xarelto blood thinner.

Janssen files sNDA to update Xarelto dosing in PI

A supplemental new drug application has been filed by Janssen seeking to update the prescribing information for Xarelto, or r -More- 

Priority review status granted to J&J for lower dose of Xarelto

Johnson & Johnson unit Janssen Research & Development's supplemental new drug application for a 10-mg daily dose of Xarelto,  -More- 

J&J and Bayer Win First Xarelto Lawsuit

Bayer and Johnson & Johnson have won the first of around 18,000 lawsuits lawsuit being brought by US patients who claim the blood-thinning drug Xarelto caused their uncontrollable brain and gastro...

Bayer and J&J Win Second Xarelto Trial

A federal court in New Orleans, Louisiana, has cleared manufacturer Bayer and its US marketing partner Johnson & Johnson of liability in the second trial of what is expected to be more than 18,000...

STAT Plus: Japanese government probes Bayer over Xarelto medical papers

A former Bayer sales rep says he was forced to gather patient data that was used to prepare medical journal papers for promoting the Xarelto blood thinner.

Xarelto API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

DelveInsight's, Xarelto API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF file...

Bayer, J&J win first trial over Xarelto bleeding risks

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drugmakers...

Matching PubMed Articles

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review.

Direct oral anticoagulants (DOACs) are in wide use among patients requiring both short- and long-term anticoagulation, mainly due to their ease of use and the lack of monitoring requirements. With gro...

Drug interaction: dabigatran (Pradaxa) and statins.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement